JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2024 ,inter alia, to consider and approve the Audited Financial Result of the company for the quarter and year ended March 31, 2024 and recommendation of dividend, if any, for the financial year ended March 31, 2024.